PHI PHARMA

Updated 6 days ago
  • ID: 47301122/32
Place du Midi 36 1950 Sion Switzerland
CLICK HERE TO SEE DETAILS OF COMPANY CHANGES
Phi's PDCs target a biologically validated and widely expressed cancer antigen that remains under-explored - Chondroitin-Sulfate Proteoglycan-4 (CSPG4).
Also known as: Phi Pharma SA
Primary location: Sion Switzerland
  • 0
  • 0
Interest Score
1
HIT Score
0.67
Founder
Christophe Bonny, Emmanuel Savioz, Patrick Berdoz
General
in..@phi-pharma.com
Domain
phi-pharma.ch
Actual
phi-pharma.com
IP
84.16.66.164
Status
OK
Category
Company
0 comments Add a comment